Form 4: Accolade Inc. Director Jeffrey S. Brodsky Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
Director Jeffrey S. Brodsky reports acquisition of 6,245 Restricted Stock Units (RSUs) in Accolade, Inc. on March 3, 2025, vesting quarterly over one year.
Summary
- On March 3, 2025, Jeffrey S. Brodsky, a director of Accolade, Inc., acquired 6,245 Restricted Stock Units (RSUs).
- These RSUs represent a contingent right to receive one share of Accolade's Common Stock each.
- The RSUs will vest at a rate of 25% each quarter, starting from March 1, 2025, provided continuous service is maintained.
- Full vesting will occur on the one-year anniversary of the Vesting Commencement Date.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock unit acquisition. The vesting schedule suggests a long-term commitment from the director.
Positives
- The acquisition of RSUs by a director signals confidence in the company's future performance.
Future Outlook
The RSUs vest over a one-year period contingent on continuous service, aligning the director's interests with the company's long-term performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.
Stakeholder Impact
- Shareholders may view the acquisition of RSUs by a director as a positive sign, indicating confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Vesting Commencement Date |
| 03/03/2025 | Transaction Date: Acquisition of Restricted Stock Units |
| 03/05/2025 | Date of Form 4 Filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.